Amanda Malone
Geschäftsführer bei EUPRAXIA PHARMACEUTICALS INC.
Vermögen: 132 078 $ am 30.04.2024
Profil
Amanda Malone is currently the Chief Operating & Scientific Officer at Eupraxia Pharmaceuticals, Inc. She previously worked as the Chief Operating Officer & Vice President at Auritec Pharmaceuticals, Inc. from 2007 to 2014.
Dr. Malone holds a graduate and doctorate degree from Stanford University and an undergraduate degree from Harvey Mudd College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
18.08.2023 | 46 343 ( 0,13% ) | 132 078 $ | 30.04.2024 |
Aktive Positionen von Amanda Malone
Unternehmen | Position | Beginn |
---|---|---|
EUPRAXIA PHARMACEUTICALS INC. | Geschäftsführer | 01.08.2012 |
Ehemalige bekannte Positionen von Amanda Malone
Unternehmen | Position | Ende |
---|---|---|
Auritec Pharmaceuticals, Inc.
Auritec Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., Auritec Pharmaceuticals, Inc. is a drug delivery company based in Santa Monica, CA. The company focuses on leveraging their scientific team's 20 years of experience in extended release delivery systems to overcome the challenges of drug delivery in bringing new therapies to patients. The company aims to develop bioavailable dosage forms and target drugs to their sites of action, as well as play major roles in the life-cycle management of older products. Auritec Pharmaceuticals has secured national institute of health (nih) funding for much of their work, indicating the level of expertise and the advanced state of their technology. | Geschäftsführer | 01.02.2014 |
Ausbildung von Amanda Malone
Harvey Mudd College | Undergraduate Degree |
Stanford University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EUPRAXIA PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Auritec Pharmaceuticals, Inc.
Auritec Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., Auritec Pharmaceuticals, Inc. is a drug delivery company based in Santa Monica, CA. The company focuses on leveraging their scientific team's 20 years of experience in extended release delivery systems to overcome the challenges of drug delivery in bringing new therapies to patients. The company aims to develop bioavailable dosage forms and target drugs to their sites of action, as well as play major roles in the life-cycle management of older products. Auritec Pharmaceuticals has secured national institute of health (nih) funding for much of their work, indicating the level of expertise and the advanced state of their technology. | Commercial Services |